- Cloud Break Therapeutics Technology (Guangzhou) Inc.
- Chongqing Anyi New Biotechnology Inc.
- Taiwan BRIM Biotechnology Inc.
- Shanghai R&R Therapeutics Inc.
- Taiwan New Drug Inc.
- Jiangsu Shenming Medical Technology Co., Ltd.
- Taiwan New Drug Inc.
China
Australia
Belgium
Germany
USA
Canada
India
Denmark
Italy
Netherland
Wuhan
USA
Australia
Nanjing
Shandong
Shanghai
Changzhou
Pharmaceutical Technology
Nuclear Medicine Anti-tumor Diagnosis and Treatment
Cerebro-cardiovascular Precision Interventional Diagnosis and Treatment
GPN00833, an improved new drug hormone nano-suspension eye drops for anti-inflammatory and pain relief after ophthalmology surgery
GPN00153, an improved new drug for the treatment of pterygium (CBT-001)
GPN00136, a world-wide innovative drug for dry eye (BRM421)
Yttrium-90 microsphere injections, the global innovative product
GPN00289, a global innovative temperature sensitive embolic agent
Lava™, a global innovative liquid embolic agent
Kona™, a global innovative liquid embolic agent
AuroLase®, a global innovative solid tumor ablation therapy
LEGFLOW® OTW, a global innovative drug-coated balloon
IVL CAD/IAL PAD, a global innovative shock wave balloon
LONG, a global innovative neurological stent retriever
aXess, a global innovative endogenous tissue repair product
